ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Business

Philippines' Ayala to build 500-bed hospitals in Manila area

QualiMed seeks to link large 'hubs' to small clinics

TOKYO -- A health care provider under the umbrella of Philippine conglomerate Ayala is planning 500-bed general hospitals in suburbs of Manila, aiming to streamline health care services by integrating large facilities with a network of small clinics.

QualiMed's first flagship hospital will open no later than 2019 in Balintawak, north of Manila. A second large hospital will be added around 2021 in an area south of Manila. QualiMed eventually aims to deploy the hospital-clinic business model in the Visayas, a group of islands in the central Philippines, as well as on the southernmost main island of Mindanao.

QualiMed is known for its price-competitiveness, offering medical services 30-40% cheaper than rivals. It has until now focused on clinics and midsize hospitals with 100 to 120 beds. But health care demand from the middle class is expanding fast as the Philippine economy grows at a rapid clip.

The new, scaled-up business model features large "hub" hospitals surrounded by clinics. Patients will be diagnosed at the clinics and transferred to the hubs if hospitalization or surgery is needed. QualiMed believes that hub-centered clinic business model will be more cost-effective than building and operating multiple midsize hospitals.

(Nikkei)

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media